Sage Journals: Discover world-class research

Free access

Case report

First published 2024-1

Niraparib-induced pure red cell aplasia

Kadriye Bir Yücel, Seyma Yıldız, Osman Sütcüoglu [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2019-10

Niraparib – A promising drug with hematological toxicity

Naga SK Patibandla, Dulabh K Monga

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2017-9

Niraparib in ovarian cancer: results to date and clinical potential

Davide Caruso, Anselmo Papa, Silverio Tomao [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2022

Quality-adjusted time without symptoms of disease or toxicity and quality-adjusted progression-free survival with niraparib maintenance in first-line ovarian cancer in the PRIMA trial

Maria-Pilar Barretina-Ginesta, Bradley J. Monk, Sileny Han [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2025-2

Whole-Exome Sequencing Identifies Germline BLM Mutation in Ovarian Hepatoid Adenocarcinoma with Favorable Response to Niraparib and Anlotinib Combination Therapy—A Case Report and Literature Review

Xiaofang Zhang, Lian Xu, Yidan Cao [...]

International Journal of Surgical Pathology

Retricted access

Research article

First published 2025-6

Efficacy and safety of niraparib in platinum-sensitive recurrent ovarian cancer: retrospective observational study in a tertiary hospital

Elena Prado-Mel, Paloma Suárez-Casillas, Lupe Rodríguez-de Francisco [...]

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2020-10

Niraparib for the Treatment of Recurrent Epithelial Ovarian,Fallopian Tube,or Primary Peritoneal Cancer

Lloreta Kerliu, Samantha Myruski, Afeefa Bhatti [...]

Annals of Pharmacotherapy

Open access

Research article

First published 2019

Severe haematological toxicities in relapsed ovarian cancer treated with olaparib or niraparib: an Italian cost-minimization analysis

Carlo Lazzaro, Nicola Amedeo Mazzanti, Fabio Parazzini

Global & Regional Health Technology Assessment: Italian;Northern Europe and Spanish

Open access

Case report

First published 2023-9

First-line maintenance therapy with niraparib in advanced platinum-sensitive ovarian cancer: two ‘long responder’ case reports and review of the current literature

Roger K. C. Ngan

Journal of International Medical Research

Open access

Research article

First published 2024

Real-world overall survival in second-line maintenance niraparib monotherapy versus active surveillance in patients with BRCA wild-type recurrent ovarian cancer

Robert L. Coleman, Jessica A. Perhanidis, Linda Kalilani [...]

Therapeutic Advances in Medical Oncology

Search results